CEA-Leti, a Grenoble, France-based research institute for electronics and information technologies, is one of the world’s largest organizations for applied research in microelectronics and nanotechnology
The Latest Bing News on:
CEA-Leti Research
- Weebit demonstrates successful scaling of its ReRAM technology to 28nm
Weebit and CEA-Leti, the French research institute recognised as a global leader in the field of microelectronics, jointly tested, characterised and measured functional 1 Megabit (Mb) ReRAM arrays in ...
- Weebit scale ReRAM to 28nm
Weebit and CEA-Leti, the French research institute, jointly tested, characterised and measured functional 1 Megabit (Mb) ReRAM arrays in a 28nm process technology on 300mm wafers, the largest diameter ...
- Weebit Nano scales its ReRAM technology to 28nm
Weebit Nano Limited (ASX:WBT), a leading developer of next-generation memory technologies for the global semiconductor industry, together with its development partner CEA-Leti, have demonstrated ...
- Weebit demonstrates successful scaling of its ReRAM technology to 28nm
Leti, demonstrate production-level parameters for its ReRAM technology at 28nm Key step in productising the technology for the embedded memory market Weebit's ReRAM technology can support smaller ...
- Weebit (ASX:WBT) successfully scales its ReRAM technology to 28nm
Weebit Nano (WBT) has successfully scaled its resistive random-access memory (ReRam) technology to 28 nanometre.
The Latest Google Headlines on:
CEA-Leti Research
The Latest Bing News on:
CEA-Leti Discovery
- Why Evolution, Northern Star, Weebit Nano, & Whitehaven Coal are rising
This follows the release of an update this morning. According to the release, together with its development partner CEA-Leti, Weebit Nano has demonstrated production-level parameters of its ...
- Here’s why the Weebit Nano (ASX:WBT) share price is jumping 14% today
According to the release, together with its development partner CEA-Leti, Weebit Nano has demonstrated production-level parameters of its Resistive Random-Access Memory (ReRAM) technology in a 28 ...
- AstraZeneca invests in Imperial's self-amplifying RNA technology with eye on future drugs
"This collaboration with VaxEquity adds a promising new platform to our drug discovery toolbox," said AstraZeneca research chief Mene Pangalos. The technology works in a similar way to the messenger ...
- RIP Medical Debt and TransUnion Healthcare Surpass $5 Billion of Medical Debt Relieved and Expand Partnership
The solutions leverage TransUnion’s holistic, data-driven Insurance Discovery and Patient Financial Clearance offerings to maximize revenue for a hospital by identifying missed insurance coverage and ...
- Aptinyx Secures $50 Million Growth Capital Credit Facility from K2 HealthVentures
About Aptinyx Aptinyx Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of proprietary synthetic small molecules for the treatment of ...
The Latest Google Headlines on:
CEA-Leti Discovery
